Table 2 Patient characteristics (n = 261)

Age (years)

 Median

73

 Mean

72.2

 Range

50–85

Follow-up

 Median (months)

61.6

n

%

Tumor stage

  ≤ T1c, T2a

163

62.5

 T2b–T2c

63

24.1

  ≥ T3a

35

13.4

Gleason score

  ≤ 6

79

30.3

 7

101

38.7

 8–10

81

31.0

PSA

  ≤ 10

123

47.1

 10–20

67

25.7

 20<

71

27.2

NCCN risk group

 Low risk

42

16.1

 Intermediate risk

95

36.4

 High risk

124

47.5

 78

22

8.4

 80

52

19.9

 82

80

30.7

 84

85

32.6

 86

22

8.4

Hormonal therapy

 (+)

193

73.9

 (−)

68

26.1